(Q55472227)

12 July 2018

title

Aberrant CpG island methylation of multiple genes in ependymal tumors. (English)

1 reference

12 July 2018

1 reference

M Eva Alonso

1

1 reference

12 July 2018

M Josefa Bello

2

1 reference

12 July 2018

Pilar Gonzalez-Gomez

3

1 reference

12 July 2018

Dolores Arjona

4

1 reference

12 July 2018

Jose M de Campos

5

1 reference

12 July 2018

Manuel Gutierrez

6

1 reference

12 July 2018

Juan A Rey

7

1 reference

12 July 2018

publication date

1 March 2004

1 reference

12 July 2018

Journal of Neuro-Oncology

published in

1 reference

12 July 2018

volume

67

1 reference

12 July 2018

page(s)

159-165

1 reference

12 July 2018

issue

1-2

1 reference

12 July 2018

https://scigraph.springernature.com/pub.10.1023/b:neon.0000021862.41799.f7

exact match

0 references

cites work

Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors.

1 reference

12 December 2020

Genetic abnormalities detected in ependymomas by comparative genomic hybridisation

1 reference

12 December 2020

Regulation of tumor growth and metastasis by thrombospondin-1.

1 reference

12 December 2020

Correlation between localization, age, and chromosomal imbalances in ependymal tumours as detected by CGH.

1 reference

12 December 2020

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

12 December 2020

Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma.

1 reference

12 December 2020

Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization.

1 reference

12 December 2020

Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers.

1 reference

12 December 2020

Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C --> A:T mutations of the TP53 tumor suppressor gene

1 reference

12 December 2020

Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN

1 reference

12 December 2020

Methylation, expression, and mutation analysis of the cell cycle control genes in human brain tumors

1 reference

12 December 2020

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

12 December 2020

Epigenetic changes in pilocytic astrocytomas and medulloblastomas.

1 reference

12 December 2020

Transcriptional inactivation of TP73 expression in oligodendroglial tumors

1 reference

12 December 2020

Promoter hypermethylation of multiple genes in astrocytic gliomas.

1 reference

12 December 2020

CpG island methylation status and mutation analysis of the RB1 gene essential promoter region and protein-binding pocket domain in nervous system tumours

1 reference

12 December 2020

Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups

1 reference

12 December 2020

Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups

1 reference

12 December 2020

Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation.

1 reference

12 December 2020

Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents

1 reference

12 December 2020

Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas

1 reference

12 December 2020

Cytogenetic evidence for a chromosome 22 tumor suppressor gene in ependymoma

1 reference

12 December 2020

A gene hypermethylation profile of human cancer

1 reference

12 December 2020

Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas

1 reference

12 December 2020

Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.

1 reference

12 December 2020

DNA hypermethylation in tumorigenesis: epigenetics joins genetics

1 reference

12 December 2020

Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas.

1 reference

12 December 2020

A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors

1 reference

12 December 2020

Distinct methylation profiles of glioma subtypes.

1 reference

12 December 2020

Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors.

1 reference

12 December 2020

Aberrant methylation of multiple genes in neuroblastic tumours. relationship with MYCN amplification and allelic status at 1p.

1 reference

12 December 2020

Alterations in DNA methylation: a fundamental aspect of neoplasia

1 reference

12 December 2020

Analysis of the NF2 gene in oligodendrogliomas and ependymomas.

1 reference

12 December 2020

Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island

1 reference

12 December 2020

Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma

1 reference

12 December 2020

CpG island methylation in sporadic and neurofibromatis type 2-associated schwannomas.

1 reference

12 December 2020

Fluorescence in situ hybridization determination of 22q12-q13 deletion in two intracerebral ependymomas.

1 reference

12 December 2020

Loss of heterozygosity for distal markers on 22q in human gliomas

1 reference

12 December 2020

Methylation of the p73 gene in gliomas

1 reference

12 December 2020

Aberrant promoter methylation of multiple genes in non-small cell lung cancers.

1 reference

12 December 2020

Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter-22q11.2.

1 reference

12 December 2020

CpG island methylation in premalignant stages of gastric carcinoma

1 reference

12 December 2020

10.1023/B:NEON.0000021862.41799.F7

Identifiers

DOI

1 reference

12 July 2018

Dimensions Publication ID

0 references

1 reference

12 July 2018